메뉴 건너뛰기




Volumn 18, Issue 5, 2008, Pages

Impact of lipoatrophy on patient-reported outcomes in antiretroviral- experienced patients

Author keywords

Antiretroviral therapy; Health related quality of life; HIV AIDS; Lipoatrophy; Literature review; Patient reported outcomes

Indexed keywords

ANABOLIC AGENT; ANTIRETROVIRUS AGENT;

EID: 43749124493     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (6)

References (68)
  • 1
    • 33748116898 scopus 로고    scopus 로고
    • Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study
    • Palella FJ, Baker RK, Moorman AC, et al. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43:27-34.
    • (2006) J Acquir Immune Defic Syndr , vol.43 , pp. 27-34
    • Palella, F.J.1    Baker, R.K.2    Moorman, A.C.3
  • 2
    • 16444367183 scopus 로고    scopus 로고
    • Mortality trends: Toward a new definition of AIDS?
    • Highleyman L. Mortality trends: toward a new definition of AIDS? BETA. 2005;17(2):18-28.
    • (2005) BETA , vol.17 , Issue.2 , pp. 18-28
    • Highleyman, L.1
  • 3
    • 43749090365 scopus 로고    scopus 로고
    • Impact of lipoatrophy on quality of life in HIV patients receiving antiretroviral therapy (ART)
    • July 19-21, Sydney, Australia. Abstract
    • Rajagopalan R, Laitinen D, Dietz B. Impact of lipoatrophy on quality of life in HIV patients receiving antiretroviral therapy (ART). Adverse Drug Reaction and Lipodystrophy Workshop in HIV; July 19-21, 2007; Sydney, Australia. Abstract P-21.
    • (2007) Adverse Drug Reaction and Lipodystrophy Workshop in HIV
    • Rajagopalan, R.1    Laitinen, D.2    Dietz, B.3
  • 4
    • 0036742741 scopus 로고    scopus 로고
    • Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients
    • Oette M, Juretzko P, Kroidl A, et al. Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patients. AIDS Patient Care STDS. 2002;16:413-417.
    • (2002) AIDS Patient Care STDS , vol.16 , pp. 413-417
    • Oette, M.1    Juretzko, P.2    Kroidl, A.3
  • 5
    • 25144459550 scopus 로고    scopus 로고
    • Laser scanning as a tool for assessment of HIV-related facial lipoatrophy: Evaluation of accuracy and reproducibility
    • Yang Y, Paton NI. Laser scanning as a tool for assessment of HIV-related facial lipoatrophy: evaluation of accuracy and reproducibility. HIV Med. 2005;6:321-325.
    • (2005) HIV Med , vol.6 , pp. 321-325
    • Yang, Y.1    Paton, N.I.2
  • 6
    • 17544375309 scopus 로고    scopus 로고
    • Interventions for managing antiretroviral therapy-associated lipoatrophy
    • Sutinen J. Interventions for managing antiretroviral therapy-associated lipoatrophy. Curr Opin Infect Dis. 2005;18:25-33.
    • (2005) Curr Opin Infect Dis , vol.18 , pp. 25-33
    • Sutinen, J.1
  • 7
    • 28344455060 scopus 로고    scopus 로고
    • Treatment of facial lipoatrophy with injections of polylactic acid in HIV-infected patients: Results from a cohort of 94 patients
    • February 8-11, San Francisco. Abstract 726
    • Lafaurie M, Dolivo M, Boulu D, et al. Treatment of facial lipoatrophy with injections of polylactic acid in HIV-infected patients: results from a cohort of 94 patients. 11th Conference on Retroviruses and Opportunistic Infections; February 8-11, 2004; San Francisco. Abstract 726.
    • (2004) 11th Conference on Retroviruses and Opportunistic Infections
    • Lafaurie, M.1    Dolivo, M.2    Boulu, D.3
  • 9
    • 33745902508 scopus 로고    scopus 로고
    • Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: A review of the clinical studies
    • Barton SE, Engelhard P, Conant M. Poly-L-lactic acid for treating HIV-associated facial lipoatrophy: a review of the clinical studies. Int J STD AIDS. 2006;17:429-435.
    • (2006) Int J STD AIDS , vol.17 , pp. 429-435
    • Barton, S.E.1    Engelhard, P.2    Conant, M.3
  • 10
    • 34547741214 scopus 로고    scopus 로고
    • Treatment for lipoatrophy: Facing the real costs
    • Margolis DM. Treatment for lipoatrophy: facing the real costs. AIDS. 2007;21:1819-1820.
    • (2007) AIDS , vol.21 , pp. 1819-1820
    • Margolis, D.M.1
  • 11
    • 33645376980 scopus 로고    scopus 로고
    • Correction options for lipoatrophy in HIV-infected patients
    • Engelhard P. Correction options for lipoatrophy in HIV-infected patients. AIDS Patient Care STDS. 2006;20:151-160.
    • (2006) AIDS Patient Care STDS , vol.20 , pp. 151-160
    • Engelhard, P.1
  • 12
    • 34548290415 scopus 로고    scopus 로고
    • Strategies in the treatment of HIV-1-associated adipose redistribution syndromes
    • del Mar Gutierrez M, Mateo G, Domingo P. Strategies in the treatment of HIV-1-associated adipose redistribution syndromes. Expert Opin Pharmacother. 2007;8:1871-1884.
    • (2007) Expert Opin Pharmacother , vol.8 , pp. 1871-1884
    • del Mar Gutierrez, M.1    Mateo, G.2    Domingo, P.3
  • 13
    • 18844428017 scopus 로고    scopus 로고
    • Therapeutic approaches to combating lipoatrophy: Do they work?
    • Martin A, Mallon PW. Therapeutic approaches to combating lipoatrophy: do they work? J Antimicrob Chemother. 2005;55:612-615.
    • (2005) J Antimicrob Chemother , vol.55 , pp. 612-615
    • Martin, A.1    Mallon, P.W.2
  • 14
    • 33644859584 scopus 로고    scopus 로고
    • HIV facial lipoatrophy: Causes and treatment options
    • Jones D. HIV facial lipoatrophy: causes and treatment options. Dermatol Surg. 2005;31(11 pt 2):1519-1529.
    • (2005) Dermatol Surg , vol.31 , Issue.11 PART 2 , pp. 1519-1529
    • Jones, D.1
  • 15
    • 6344282674 scopus 로고    scopus 로고
    • Editorial: The needs-based approach to quality of life assessment
    • McKenna SP, Doward LC. Editorial: the needs-based approach to quality of life assessment. Value Health. 2004;7(suppl 1):S1-S3.
    • (2004) Value Health , vol.7 , Issue.SUPPL. 1
    • McKenna, S.P.1    Doward, L.C.2
  • 16
    • 33646436423 scopus 로고    scopus 로고
    • Effect of antiretroviral therapy on the quality of patient's life
    • Cholewínska G. Effect of antiretroviral therapy on the quality of patient's life. HIV AIDS Rev. 2005;4:35-41.
    • (2005) HIV AIDS Rev , vol.4 , pp. 35-41
    • Cholewínska, G.1
  • 18
    • 22144486633 scopus 로고    scopus 로고
    • Relationship between lipoatrophy and quality of life
    • Echavez M, Horstman W. Relationship between lipoatrophy and quality of life. AIDS Reader. 2005;15:369-375.
    • (2005) AIDS Reader , vol.15 , pp. 369-375
    • Echavez, M.1    Horstman, W.2
  • 19
    • 6344253018 scopus 로고    scopus 로고
    • Defining patient-reported outcomes
    • Doward LC, McKenna SP. Defining patient-reported outcomes. Value Health. 2004;7(suppl 1):S4-S8.
    • (2004) Value Health , vol.7 , Issue.SUPPL. 1
    • Doward, L.C.1    McKenna, S.P.2
  • 20
    • 6344231646 scopus 로고    scopus 로고
    • Requirements for quality of life instruments in clinical research
    • Doward LC, Meads DM, Thorsen H. Requirements for quality of life instruments in clinical research. Value Health. 2004;7(suppl 1):S13-S16.
    • (2004) Value Health , vol.7 , Issue.SUPPL. 1
    • Doward, L.C.1    Meads, D.M.2    Thorsen, H.3
  • 21
    • 0037395720 scopus 로고    scopus 로고
    • A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals
    • Power R, Tate HL, McGill SM, Taylor C. A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals. Sex Transm Infect. 2003;79:137-141.
    • (2003) Sex Transm Infect , vol.79 , pp. 137-141
    • Power, R.1    Tate, H.L.2    McGill, S.M.3    Taylor, C.4
  • 22
    • 0033809393 scopus 로고    scopus 로고
    • Psychosocial impact of the lipodystrophy syndrome in HIV infection
    • Collins E, Wagner C, Walmsley S. Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Reader. 2000;10:546-550.
    • (2000) AIDS Reader , vol.10 , pp. 546-550
    • Collins, E.1    Wagner, C.2    Walmsley, S.3
  • 23
    • 33751093063 scopus 로고    scopus 로고
    • Impact of lipodystrophy on quality of life
    • July 9-14, Durban, South Africa. Abstract WePpB1381
    • Goetzenich A, Corzillius M, Mauss S, et al. Impact of lipodystrophy on quality of life. 13th International AIDS Conference; July 9-14, 2000; Durban, South Africa. Abstract WePpB1381.
    • (2000) 13th International AIDS Conference
    • Goetzenich, A.1    Corzillius, M.2    Mauss, S.3
  • 24
    • 18844408365 scopus 로고    scopus 로고
    • The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults
    • Burgoyne R, Collins E, Wagner C, et al. The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults. Qual Life Res. 2005;14:981-990.
    • (2005) Qual Life Res , vol.14 , pp. 981-990
    • Burgoyne, R.1    Collins, E.2    Wagner, C.3
  • 25
    • 33748684776 scopus 로고    scopus 로고
    • Balancing disfigurement and fear of disease progression: Patient perceptions of HIV body fat redistribution
    • Reynolds NR, Neidig JL, Wu AW, et al. Balancing disfigurement and fear of disease progression: patient perceptions of HIV body fat redistribution. AIDS Care. 2006;18:663-673.
    • (2006) AIDS Care , vol.18 , pp. 663-673
    • Reynolds, N.R.1    Neidig, J.L.2    Wu, A.W.3
  • 26
    • 27944493963 scopus 로고    scopus 로고
    • Self-perception of body changes in persons living with HIV/AIDS: Prevalence and associated factors
    • Santos CP, Felipe YX, Braga PE, et al. Self-perception of body changes in persons living with HIV/AIDS: prevalence and associated factors. AIDS. 2005;19(suppl 4):S14-S21.
    • (2005) AIDS , vol.19 , Issue.SUPPL. 4
    • Santos, C.P.1    Felipe, Y.X.2    Braga, P.E.3
  • 27
    • 43749098455 scopus 로고    scopus 로고
    • Peripheral fat depletion (lipoatrophy) and other body shape changes - impact on psychosocial quality of life
    • July 9-14, Durban, South Africa. Abstract WePeD4566
    • Forrester J, Whittaker W, Workman C. Peripheral fat depletion (lipoatrophy) and other body shape changes - impact on psychosocial quality of life. 13th International AIDS Conference; July 9-14, 2000; Durban, South Africa. Abstract WePeD4566.
    • (2000) 13th International AIDS Conference
    • Forrester, J.1    Whittaker, W.2    Workman, C.3
  • 28
    • 0037114879 scopus 로고    scopus 로고
    • Relationship between HAART adherence and adipose tissue alterations
    • Ammassari A, Antinori A, Cozzi-Lepri A, et al. Relationship between HAART adherence and adipose tissue alterations. J Acquir Immune Defic Syndr. 2002;31(suppl 3):S140-S144.
    • (2002) J Acquir Immune Defic Syndr , vol.31 , Issue.SUPPL. 3
    • Ammassari, A.1    Antinori, A.2    Cozzi-Lepri, A.3
  • 29
    • 0037111631 scopus 로고    scopus 로고
    • Lipodystrophy in a cohort of human immunodeficiency virus-infected Asian patients: Prevalence, associated factors, and psychological impact
    • Paton NI, Earnest A, Ng YM, et al. Lipodystrophy in a cohort of human immunodeficiency virus-infected Asian patients: prevalence, associated factors, and psychological impact. Clin Infect Dis. 2002;35:1244-1249.
    • (2002) Clin Infect Dis , vol.35 , pp. 1244-1249
    • Paton, N.I.1    Earnest, A.2    Ng, Y.M.3
  • 30
    • 25144455962 scopus 로고    scopus 로고
    • Lipodystrophy-associated symptoms and medication adherence in HIV/AIDS
    • Corless IB, Kirksey KM, Kemppainen J, et al. Lipodystrophy-associated symptoms and medication adherence in HIV/AIDS. AIDS Patient Care STDS. 2005;19:577-586.
    • (2005) AIDS Patient Care STDS , vol.19 , pp. 577-586
    • Corless, I.B.1    Kirksey, K.M.2    Kemppainen, J.3
  • 31
    • 0003316261 scopus 로고    scopus 로고
    • The impact of patient perceptions of body shape changes and metabolic abnormalities on ART
    • July 9-14, Durban, South Africa. Abstract WePpB138
    • Kasper TB, Arboleda CH, Halpern MT. The impact of patient perceptions of body shape changes and metabolic abnormalities on ART. 13th International AIDS Conference; July 9-14, 2000; Durban, South Africa. Abstract WePpB138.
    • (2000) 13th International AIDS Conference
    • Kasper, T.B.1    Arboleda, C.H.2    Halpern, M.T.3
  • 32
    • 36148946474 scopus 로고    scopus 로고
    • Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda
    • Mutimura E, Stewart A, Crowther NJ. Assessment of quality of life in HAART-treated HIV-positive subjects with body fat redistribution in Rwanda. AIDS Res Ther. 2007;4:19.
    • (2007) AIDS Res Ther , vol.4 , pp. 19
    • Mutimura, E.1    Stewart, A.2    Crowther, N.J.3
  • 33
    • 12144287591 scopus 로고    scopus 로고
    • Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: Results of the open-label study VEGA
    • Valantin M, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003;17:2471-2477.
    • (2003) AIDS , vol.17 , pp. 2471-2477
    • Valantin, M.1    Aubron-Olivier, C.2    Ghosn, J.3
  • 34
    • 10744229634 scopus 로고    scopus 로고
    • No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: Randomised, double-blind, placebo-controlled trial
    • Carr A, Workman C, Carey D, et al. No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial. Lancet. 2004;363:429-438.
    • (2004) Lancet , vol.363 , pp. 429-438
    • Carr, A.1    Workman, C.2    Carey, D.3
  • 35
    • 0036190733 scopus 로고    scopus 로고
    • DAGNA Lipantiretoviral therapy study group. Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment
    • Mauss S, Corzillius M, Wolf E, et al; DAGNA Lipantiretoviral therapy study group. Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3 years of antiretroviral treatment. HIV Med. 2002;3:49-55.
    • (2002) HIV Med , vol.3 , pp. 49-55
    • Mauss, S.1    Corzillius, M.2    Wolf, E.3
  • 36
    • 43749117886 scopus 로고    scopus 로고
    • Psychological assessment of HIV-infected patients with facial lipoatrophy before and after reparatory treatment
    • July 11-16, Bangkok, Thailand. Abstract WePeB5930
    • Fumaz CR, Muñoz-Moreno JA, Ferrer MJ, et al. Psychological assessment of HIV-infected patients with facial lipoatrophy before and after reparatory treatment. 15th International AIDS Conference; July 11-16, 2004; Bangkok, Thailand. Abstract WePeB5930.
    • (2004) 15th International AIDS Conference
    • Fumaz, C.R.1    Muñoz-Moreno, J.A.2    Ferrer, M.J.3
  • 40
    • 0030847865 scopus 로고    scopus 로고
    • Evidence for reliability, validity, and usefulness of Medical Outcomes Study HIV Health Survey (MOS-HIV)
    • Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity, and usefulness of Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997;6:481-493.
    • (1997) Qual Life Res , vol.6 , pp. 481-493
    • Wu, A.W.1    Revicki, D.A.2    Jacobson, D.3    Malitz, F.E.4
  • 41
    • 33846203789 scopus 로고    scopus 로고
    • Reconstructive treatment for antiretroviral-associated facial lipoatrophy: A prospective study comparing autologous fat and synthetic substances
    • Negredo E, Higueras C, Adell X, et al. Reconstructive treatment for antiretroviral-associated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances. AIDS Patient Care STDS. 2006;20:829-837.
    • (2006) AIDS Patient Care STDS , vol.20 , pp. 829-837
    • Negredo, E.1    Higueras, C.2    Adell, X.3
  • 42
    • 0037055028 scopus 로고    scopus 로고
    • Mitochondrial Toxicity (MITOX) study group. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: A randomized trial
    • Carr A, Workman C, Smith DE, et al; Mitochondrial Toxicity (MITOX) study group. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial. JAMA. 2002;288:207-215.
    • (2002) JAMA , vol.288 , pp. 207-215
    • Carr, A.1    Workman, C.2    Smith, D.E.3
  • 43
    • 0025688231 scopus 로고
    • EuroQol - a new facility for the measurement of health-related quality of life
    • The EuroQol Group
    • The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
    • (1990) Health Policy , vol.16 , pp. 199-208
  • 44
    • 0026667228 scopus 로고
    • Validating the SF-36 health survey questionnaire: New outcome measure for primary care
    • Brazier JE, Harper R, Jones NM, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305:160-164.
    • (1992) BMJ , vol.305 , pp. 160-164
    • Brazier, J.E.1    Harper, R.2    Jones, N.M.3
  • 45
    • 0027292883 scopus 로고
    • Testing the validity of the EuroQoL and comparing it with the SF-36 health survey questionnaire
    • Brazier J, Jones N, Kind P. Testing the validity of the EuroQoL and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2:169-180.
    • (1993) Qual Life Res , vol.2 , pp. 169-180
    • Brazier, J.1    Jones, N.2    Kind, P.3
  • 46
    • 34248512901 scopus 로고    scopus 로고
    • Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients
    • Loutfy MR, Raboud JM, Antoniou T, et al. Immediate versus delayed polyalkylimide gel injections to correct facial lipoatrophy in HIV-positive patients. AIDS. 2007;21:1147-1155.
    • (2007) AIDS , vol.21 , pp. 1147-1155
    • Loutfy, M.R.1    Raboud, J.M.2    Antoniou, T.3
  • 47
    • 0031051937 scopus 로고    scopus 로고
    • Dermatology quality of life scales - a measure of the impact of skin diseases
    • Morgan M, McCreedy R, Simpson J, Hay RJ. Dermatology quality of life scales - a measure of the impact of skin diseases. Br J Dermatol. 1997;136:202-206.
    • (1997) Br J Dermatol , vol.136 , pp. 202-206
    • Morgan, M.1    McCreedy, R.2    Simpson, J.3    Hay, R.J.4
  • 48
    • 0020527558 scopus 로고
    • The hospital anxiety and depression scale
    • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
    • (1983) Acta Psychiatr Scand , vol.67 , pp. 361-370
    • Zigmond, A.S.1    Snaith, R.P.2
  • 49
    • 33645100143 scopus 로고    scopus 로고
    • Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy
    • Cattelan AM, Bauer U, Trevenzoli M, et al. Use of polylactic acid implants to correct facial lipoatrophy in human immunodeficiency virus 1-positive individuals receiving combination antiretroviral therapy. Arch Dermatol. 2006;142:329-334.
    • (2006) Arch Dermatol , vol.142 , pp. 329-334
    • Cattelan, A.M.1    Bauer, U.2    Trevenzoli, M.3
  • 50
    • 1642524396 scopus 로고    scopus 로고
    • A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection
    • Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5:82-87.
    • (2004) HIV Med , vol.5 , pp. 82-87
    • Moyle, G.J.1    Lysakova, L.2    Brown, S.3
  • 51
    • 33750227103 scopus 로고    scopus 로고
    • Moyle GJ, Sabin CA, Cartledge J, et al; Rave (Randomized Abacavir versus Viread Evaluation) Group UK. A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. AIDS. 2006;20:2043-2050.
    • Moyle GJ, Sabin CA, Cartledge J, et al; Rave (Randomized Abacavir versus Viread Evaluation) Group UK. A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. AIDS. 2006;20:2043-2050.
  • 52
    • 15044346198 scopus 로고    scopus 로고
    • Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients
    • Lafaurie M, Dolivo M, Porcher R, et al. Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients. J Acquir Immune Defic Syndr. 2005;38:393-398.
    • (2005) J Acquir Immune Defic Syndr , vol.38 , pp. 393-398
    • Lafaurie, M.1    Dolivo, M.2    Porcher, R.3
  • 53
    • 0026877917 scopus 로고
    • The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection
    • Ware JE, Sherbourne CD. The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-483.
    • (1992) Med Care , vol.30 , pp. 473-483
    • Ware, J.E.1    Sherbourne, C.D.2
  • 54
    • 36549015755 scopus 로고    scopus 로고
    • Facial LipoAtrophy Study in HIV Investigators. A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy
    • Carey DL, Baker D, Rogers GD, et al; Facial LipoAtrophy Study in HIV Investigators. A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy. J Acquir Immune Defic Syndr. 2007;46:581-589.
    • (2007) J Acquir Immune Defic Syndr , vol.46 , pp. 581-589
    • Carey, D.L.1    Baker, D.2    Rogers, G.D.3
  • 55
    • 0029975592 scopus 로고    scopus 로고
    • The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population
    • O'Keefe EA, Wood R. The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population. Qual Life Res. 1996;5:275-280.
    • (1996) Qual Life Res , vol.5 , pp. 275-280
    • O'Keefe, E.A.1    Wood, R.2
  • 57
    • 11344275569 scopus 로고    scopus 로고
    • Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy
    • Abstract 56
    • Mest DR, Humble G. Safety and efficacy of intradermal poly-L-lactic acid (Sculptra) injections in patients with HIV-associated facial lipoatrophy. Antivir Ther. 2004;9:L36. Abstract 56.
    • (2004) Antivir Ther , vol.9
    • Mest, D.R.1    Humble, G.2
  • 58
    • 33750609380 scopus 로고    scopus 로고
    • Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: The US experience
    • Mest DR, Humble G. Safety and efficacy of poly-L-lactic acid injections in persons with HIV-associated lipoatrophy: the US experience. Dermatol Surg. 2006;32:1336-1345.
    • (2006) Dermatol Surg , vol.32 , pp. 1336-1345
    • Mest, D.R.1    Humble, G.2
  • 59
    • 34249658315 scopus 로고    scopus 로고
    • Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging
    • Hanke CW, Redbord KP. Safety and efficacy of poly-L-lactic acid in HIV lipoatrophy and lipoatrophy of aging. J Drugs Dermatol. 2007;6:123-128.
    • (2007) J Drugs Dermatol , vol.6 , pp. 123-128
    • Hanke, C.W.1    Redbord, K.P.2
  • 60
    • 0037183921 scopus 로고    scopus 로고
    • Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue
    • Levan P, Nguyen TH, Lallemand F, et al. Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue. AIDS. 2002;16:1985-1987.
    • (2002) AIDS , vol.16 , pp. 1985-1987
    • Levan, P.1    Nguyen, T.H.2    Lallemand, F.3
  • 61
    • 85011374820 scopus 로고    scopus 로고
    • Psychosocial adjustment to facial lipoatrophy in people with HIV
    • Abstract 34
    • O'Donovan CA, Hourihan M, Petrak J, Murphy M. Psychosocial adjustment to facial lipoatrophy in people with HIV. Antivir Ther. 2005;10:L24. Abstract 34.
    • (2005) Antivir Ther , vol.10
    • O'Donovan, C.A.1    Hourihan, M.2    Petrak, J.3    Murphy, M.4
  • 62
    • 84952922185 scopus 로고    scopus 로고
    • Rosenberg M. Society and the Adolescent Self-image. Princeton, NJ: Princeton University Press; 1965.
    • Rosenberg M. Society and the Adolescent Self-image. Princeton, NJ: Princeton University Press; 1965.
  • 63
    • 20344364086 scopus 로고    scopus 로고
    • Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy
    • Burgess CM, Quiroga RM. Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52:233-239.
    • (2005) J Am Acad Dermatol , vol.52 , pp. 233-239
    • Burgess, C.M.1    Quiroga, R.M.2
  • 64
    • 27144477778 scopus 로고    scopus 로고
    • Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this technique
    • Burnouf M, Buffet M, Schwarzinger M, et al. Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this technique. Arch Dermatol. 2005;141:1220-1224.
    • (2005) Arch Dermatol , vol.141 , pp. 1220-1224
    • Burnouf, M.1    Buffet, M.2    Schwarzinger, M.3
  • 65
    • 43749116800 scopus 로고    scopus 로고
    • Intradermal polylactic acid (Newfill) for treatment of severe HIV-associated facial lipoatrophy
    • April 19-21, York, United Kingdom. Abstract O13
    • Day JN, Raabe A, Shiner AM, Wilkins EL. Intradermal polylactic acid (Newfill) for treatment of severe HIV-associated facial lipoatrophy. 8th Annual conference of the British HIV Association; April 19-21, 2002; York, United Kingdom. Abstract O13.
    • (2002) 8th Annual conference of the British HIV Association
    • Day, J.N.1    Raabe, A.2    Shiner, A.M.3    Wilkins, E.L.4
  • 66
    • 34247124454 scopus 로고    scopus 로고
    • Effectiveness of subcutaneous growth hormone in HIV-1 patients with moderate to severe facial lipoatrophy
    • Honda M, Yogi A, Ishizuka N, et al. Effectiveness of subcutaneous growth hormone in HIV-1 patients with moderate to severe facial lipoatrophy. Intern Med. 2007;46:359-362.
    • (2007) Intern Med , vol.46 , pp. 359-362
    • Honda, M.1    Yogi, A.2    Ishizuka, N.3
  • 67
    • 34249865891 scopus 로고    scopus 로고
    • A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy
    • Cavalcanti R, Raboud J, Shen S, et al. A randomized, placebo-controlled trial of rosiglitazone for HIV-related lipoatrophy. J Infect Dis. 2007;195:1754-1761.
    • (2007) J Infect Dis , vol.195 , pp. 1754-1761
    • Cavalcanti, R.1    Raboud, J.2    Shen, S.3
  • 68
    • 31644438879 scopus 로고    scopus 로고
    • Appearance-related side effects of HIV-1 treatment
    • Hawkins T. Appearance-related side effects of HIV-1 treatment. AIDS Patient Care STDS. 2006;20:6-18.
    • (2006) AIDS Patient Care STDS , vol.20 , pp. 6-18
    • Hawkins, T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.